维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Dezaki"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca^2+ signaling in β-cell: Implication in the glycemic control in rodents显示文摘	Dezaki H Hosoda H Kakei M	2004	Diabetes2004，53，：	1
2	Complementary effects of paeoniflorin and glycyrrhizin on intraeellular Ca2 + mobilization in the nerve - stimu- lated skeletal muscle of mice 显示文摘	Dezaki K Miyahara K Kimur M	1995	Jpn J Pharmacol1995，69，3：	1
3	Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca^2+ signaling in β-cells 显示文摘	Dezaki K Hosoda H Kakei M	2004	Diabetes2004，53，12：	1
4	Inhibition of insulin secretion from rat pancreatic islets by dexmedetomidine and medetomidine, two sedatives frequently used in clinical settings 显示文摘	Kodera SY Yoshida M Dezaki K	2013	Endocr J2013，60，3：	1
5	Ghrehn is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis显示文摘	Dezaki K Sone H Yada T	2008	Pharmacol Therap2008，118，2：	1
6	Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance显示文摘	Dezaki K Sone H Koizumi M	2006	Diabetes2006，55，12：	1
7	Endogenous ghrelin in pancreatic islet restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents 显示文摘	Dezaki K Hosoda H Kakei M	2004	Diabetes2004，53，12：	1
8	Ghrelin uses Galphai2 and activates voltage-dependent K+ channels to attenuate glucose-induced Ca2+ signaling and insulin release in islet beta-cells:novel signal transduction of ghrelin显示文摘	Dezaki K Kakei M Yada T	2007	Diabetes2007，56，9：	1
9	Inhibition of insulin secretion from rat pancreatic islets by dexmedetomidine and medetomidine,two sedatives frequently used in clinical settings显示文摘	Kodera SY Yoshida M Dezaki K	2013	Endocr J2013，60，3：	1
10	Ghrelin attenuatescAMP-PKA signaling to evoke insulinostatic cascade inisletJ3-cells显示文摘	Dezaki K Damdindorj B Sone H	2011	Original Article2011，60，：	1
11	Inhibition of insulin se- cretion from rat pancreatic islets by dexmedetomidie and medeto- midine, two sedatives frequently used in clinical settings显示文摘	Kodera SY Yoshida M Dezaki K	2013	En- docr J2013，60，3：	1
12	Lack of TRPM2impaired insulin secretion and glucose metabolisms in mice显示文摘	Uchida K Dezaki K Damdindorj B Inada H Shiuchi T Mori Y	2011	Diabetes2011，60，1：	1
13	Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis 显示文摘	Dezaki K Sone H Yada T	2008	Pharmacol Therap2008，118，2：	1
14	Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis显示文摘	Katsuya Dezaki Hedeyuki Sone Toshihiko Yada	2008	Pharmacology and Therapeutics2008，，2：	1
15	Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis显示文摘	Katsuya Dezaki Hedeyuki Sone Toshihiko Yada	2008	Pharmacology and Therapeutics2008，，2：	1
16	Endogenous ghrelin in pancreatic islets restricts insulin release by atteuating Ca2+ signaling in β-cells显示文摘	Dezaki K Hosoda H Kakei M		0，，12：	1
17	The β-cell GHSR and downstream cAMP/TRPM2 signaling account for insulinostatic and glycemic effects of ghrelin显示文摘	Kurashina T Dezaki K Yoshida M	2015	Sci Rep2015，5，14：	1
18	Ghrelin uses Gai2 and activates voltage-dependent K+channels to attenuate glucose-induced Ca^2+signaling and insulin release in islet beta-cells :novel signal transduction of ghrelin显示文摘	Dezaki K Kakei M Yada T	2007	Diabetes2007，56，9：	1
19	Inhibition of insulin secretion from rat pancreatic islets by dexmedetomidine and medetomidine,two sedatives frequently used in clinical settings 显示文摘	Kodera SY Yoshida M Dezaki K	2013	Endocr2013，60，3：	1
20	Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in β-cells显示文摘	Dezaki K Hosoda H Kakei M		0，，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示